ATS 2024 Final Program

Click on the session title to view the speakers

292

TUESDAY • MAY 21

3:15 Monitoring the Environment and Biomonitoring Workers for Ultrafine Particle Exposure 3:30 The Challenge of Detecting Small Airways Disease Associated with Deployment

BASIC • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM

C84 NOVEL AND NEGLECTED

ENVIRONMENTAL EXPOSURES AND LUNG HEALTH

CLINICAL SCIENTIFIC SYMPOSIUM

Assemblies on Respiratory Structure and Function; Environmental, Occupational and Population Health; Respiratory Cell and Molecular Biology 2:15 p.m. - 3:45 p.m. Target Audience Pulmonologists, environmental scientists, occupational medicine specialists, basic and clinic public health professionals Objectives At the conclusion of this session, the participant will be able to: • understand the various types of novel environmental and occupational exposures affecting lung health and the cellular and molecular mechanisms underlying their damaging effects • describe new findings about detection of exposure and lung damage to inhaled toxicants using novel screening and imaging techniques • more appropriately refer or counsel patients earlier on the basis of increased knowledge of the risks and consequences of environmental and occupational exposures This symposium will highlight the impact of environmental exposures to various inhaled toxins and pollutants, describing the mechanisms underlying their toxicity and potential for initiating or exacerbating lung diseases. The speakers will focus on the risks and consequences of exposure to respirable silica, wildfire smoke and microplastics for both exposed workers and the wider community, highlighting the disparities between high, middle and low income countries. This session will also explore preventative measures, regulatory strategies, and novel approaches for surveillance of those exposed and at risk of environment-induced respiratory conditions. 2:15 Engineered Stone Dust: A Lot of Silica and More 2:30 Are Airborne Microplastics the New Threat to Our Lungs? 2:45 Effects of Pollution Caused by Burning Sugar Cane and Forest Fires on Health - Evidence from Brazilian Research 3:00 Environmental Exposures Adding to the Burden of Existing Lung Disease San Diego Convention Center Room 6D (Upper Level)

C85 ATS DOCUMENTS: ADVANCING AND IMPROVING CLINICAL PRACTICE Assemblies on Behavioral Science and Health Services Research; Clinical Problems; Critical Care; Sleep and Respiratory Neurobiology; This proposal is jointly sponsored by the PRS and the Quality Improvement and Implementation Committee chairs.; Documents Development and Implementation Committee 2:15 p.m. - 3:45 p.m. Target Audience Physicians, Nurses, Respiratory therapists, Educators, Trainees Objectives At the conclusion of this session, the participant will be able to: • understand how evidence is used to inform diagnostic and treatment recommendations • improve patient outcomes by applying recommendations from recently published clinical practice guidelines • learn new strategies to approach: scleroderma-related interstitial lung disease, pediatric obstructive sleep apnea following adenotonsillectomy, the management of ARDS, as well as time-limited trials in critical care This session is proposed as the 9th annual scientific symposium highlighting ATS documents, with a focus on clinical practice guidelines, as requested by the ATS Executive Committee. This year’s symposium will highlight the following guidelines: Management of ARDS, Treatment of Scleroderma-related Interstitial Lung Disease, and Pediatric OSA following Adenotonsillectomy. Additionally, the symposium will highlight the following workshop report: Defining Time-Limited Trials in Critical Care. Speakers will describe how ATS documents provide the foundation for advancing and improving clinical practice. 2:15 Welcome and Introduction 2:20 Clinical Practice Guideline Methodology San Diego Convention Center Room 8 (Upper Level)

ATS 2024 Conference Program • San Diego, CA